|Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues|
LM Ebert, P Schaerli, B Moser
Molecular immunology 42 (7), 799-809, 2005
|Homing and function of human skin γδ T cells and NK cells: relevance for tumor surveillance|
LM Ebert, S Meuter, B Moser
The Journal of Immunology 176 (7), 4331-4336, 2006
|The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells|
LM Ebert, BS Tan, J Browning, S Svobodova, SE Russell, N Kirkpatrick, ...
Cancer research 68 (8), 3001-3009, 2008
|A skin-selective homing mechanism for human immune surveillance T cells|
P Schaerli, L Ebert, K Willimann, A Blaser, RS Roos, P Loetscher, ...
Journal of Experimental Medicine 199 (9), 1265-1275, 2004
|Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation|
P Schaerli, K Willimann, LM Ebert, A Walz, B Moser
Immunity 23 (3), 331-342, 2005
|Chemokines: extracellular messengers for all occasions?|
LM Gale, SR McColl
Bioessays 21 (1), 17-28, 1999
|Regulatory T-cell–Mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma|
T Nicholaou, LM Ebert, ID Davis, GA McArthur, H Jackson, N Dimopoulos, ...
Clinical Cancer Research 15 (6), 2166-2173, 2009
|Directions in the immune targeting of cancer: lessons learned from the cancer‐testis Ag NY‐ESO‐1|
T Nicholaou, L Ebert, ID Davis, N Robson, O Klein, E Maraskovsky, ...
Immunology and cell biology 84 (3), 303-317, 2006
|Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes|
LM Ebert, SR McColl
The Journal of Immunology 168 (1), 65-72, 2002
|Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4|
O Klein, LM Ebert, T Nicholaou, J Browning, SE Russell, M Zuber, ...
Clinical cancer research 15 (7), 2507-2513, 2009
|A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design|
LM Ebert, YC Liu, CS Clements, NC Robson, HM Jackson, JL Markby, ...
Cancer research 69 (3), 1046-1054, 2009
|B cells alter the phenotype and function of follicular‐homing CXCR5+ T cells|
LM Ebert, MP Horn, AB Lang, B Moser
European journal of immunology 34 (12), 3562-3571, 2004
|Lymphocyte traffic control by chemokines: follicular B helper T cells|
B Moser, L Ebert
Immunology letters 85 (2), 105-112, 2003
|Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation|
LM Ebert, SR McColl
The Journal of Immunology 166 (8), 4870-4878, 2001
|A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties|
MR Pitman, JA Powell, C Coolen, PAB Moretti, JR Zebol, DH Pham, ...
Oncotarget 6 (9), 7065, 2015
|A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma|
LM Ebert, SE MacRaild, D Zanker, ID Davis, J Cebon, W Chen
PloS one 7 (10), e48424, 2012
|FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.|
BS Tan, M Anaka, S Deb, C Freyer, LM Ebert, AC Chueh, S Al-Obaidi, ...
Oncotarget 5 (1), 264, 2014
|Flt3 ligand expands CD4+FoxP3+ regulatory T cells in human subjects|
O Klein, LM Ebert, D Zanker, K Woods, BS Tan, J Fucikova, A Behren, ...
European journal of immunology 43 (2), 533-539, 2013
|Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments|
SL Perrin, MS Samuel, B Koszyca, MP Brown, LM Ebert, M Oksdath, ...
Biochemical Society Transactions 47 (2), 625-638, 2019
|Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome|
LY Tan, C Mintoff, MZ Johan, BW Ebert, C Fedele, YF Zhang, P Szeto, ...
Oncotarget 7 (29), 46492, 2016